The FDA’s clearance could double Kisqali’s breast cancer market. Elsewhere, Novo is exploring new ways to deliver genetic ...

Kacholia turned heads when he exited these stocks between December 2023 and June 2024. Was it a mistake or will his decision ...

“The expansion of our Singapore site will strengthen our global manufacturing capabilities ... employing around 7,000 employees, with Amgen, GSK, Pfizer, Sanofi, MSD, Novartis, and Roche ...

This led to some of the major pharma companies setting up shop in the country, such as Novartis, GSK, and others ... of the other two Lilly sites in Ireland – at the manufacturing site at ...

However, the analysts said: “Given our own forecast that CPI inflation will rise back to 2.9pc by January next year (perhaps ...

British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.

This summer, GSK cut its yearly vaccine sales projection ... related to vaccine administration such as pain at the injection site, fatigue and muscle pain. The duration of those events were ...

GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the ...